1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid
(KIHYPELVXPAIDH-HNSNBQBZSA-N)
Structure
- SMILES
- CCc1cc(ccc1CN1CC(C1)C(=O)O)/C(=N/OCc1ccc(c(c1)C(F)(F)F)C1CCCCC1)/C
- Type(s)
- Approved; Investigational
- Molecular Formula:
- C29H35F3N2O3
- Molecular Weight:
- 516.595
- Log P:
- 6.7106
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 1
- TPSA:
- 62.13
- CAS Number(s):
- 1230487-00-9; 1230487-85-0
Synonym(s)
1.
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid
2.
BAF-312
3.
BAF312
4.
siponimod
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Basal cell carcinoma | FAERS: 1 | US FAERS | |
| 2 | Chemical and Drug Induced Liver Injury | 29556671 | CTD | |
| 3 | Hemangiosarcoma | 29556671 | CTD | |
| 4 | Multiple Sclerosis | 29556671 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.